HomeInsights52 Week High Stocks

Suven Pharmaceuticals Ltd 52 Week High

Suven Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 2.0 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

19.0 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Suven Pharmaceuticals Ltd

NSE: SUVENPHAR

YEARHIGH

₹ 1359

Last updated on: Jan 15, 2025

Key Highlights

  • The 52 Week HIGH of Suven Pharmaceuticals Ltd is ₹ 1359 as of 15 Jan 25 .

Company Fundamentals for Suven Pharmaceuticals Ltd

No data available

Market Price of Suven Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Suven Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251055.15
14 Jan 20251054.75
13 Jan 20251049.95
10 Jan 20251061.9
09 Jan 20251103.55
08 Jan 20251102.1
07 Jan 20251092.8
06 Jan 20251092.2
03 Jan 20251105.75
02 Jan 20251114.4

Asset Value vs Market Value of Suven Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Suven Pharmaceuticals Ltd News Hub

News

Suven Pharmaceuticals schedules board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

28 Dec 2024 09:36

News

Suven Pharmaceuticals acquires 56% stake in NJ Bio Inc.

Suven Pharmaceuticals has acquired 56% equity share capital of NJ Bio, Inc. (target compan...

Read more

23 Dec 2024 11:34

News

Suven Pharmaceuticals strengths its ADC offering with acquisition of NJ Bio

Suven Pharmaceuticals announced the acquisition of a controlling stake in NJ Bio Inc. (NJ ...

Read more

07 Dec 2024 11:24

News

Suven Pharmaceuticals to acquire majority stake in US based NJ Bio

Suven Pharmaceuticals has executed definitive agreements today, i.e. 07 December 2024, for...

Read more

07 Dec 2024 11:20

News

Suven Pharma to acquire majority stake in US-based NJ Bio

The $64.4 million deal includes both primary equity infusion and secondary acquisition. As...

Read more

07 Dec 2024 17:20

News

Suven Pharmaceuticals Ltd Surges 4.23%

Suven Pharmaceuticals Ltd gained 4.23% today to trade at Rs 1359. The BSE Healthcare index...

Read more

02 Dec 2024 09:30

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Suven Pharmaceuticals Ltd

What is the significance of Suven Pharmaceuticals Ltd reaching its 52-week high?

Suven Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Suven Pharmaceuticals Ltd 52-week high?

Investors monitor Suven Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Suven Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Suven Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Suven Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Suven Pharmaceuticals Ltd at its 52-week high?

Before investing in Suven Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Suven Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Suven Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions